1 – 8 of 8
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Osteosarcomas With Few Chromosomal Alterations or Adult Onset Are Genetically Heterogeneous
(
- Contribution to journal › Article
-
Mark
CDK4 is co-amplified with either TP53 promoter gene fusions or MDM2 through distinct mechanisms in osteosarcoma
(
- Contribution to journal › Article
-
Mark
Disruption of the TP53 locus in osteosarcoma leads to TP53 promoter gene fusions and restoration of parts of the TP53 signalling pathway
(
- Contribution to journal › Article
- 2022
-
Mark
Methylation and copy number profiling : emerging tools to differentiate osteoblastoma from malignant mimics?
(
- Contribution to journal › Article
-
Mark
Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM
(
- Contribution to journal › Article
- 2021
-
Mark
The pediatric precision oncology INFORM registry : clinical outcome and benefit for patients with very high-evidence targets
(
- Contribution to journal › Article
- 2020
-
Mark
NTRK fusions in osteosarcoma are rare and non-functional events
(
- Contribution to journal › Article
- 2016
-
Mark
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1) : an open-label, international, randomised controlled trial
(
- Contribution to journal › Article